Durham Spencer H, Hohmann Natalie S, Ragan Addison H
Department of Pharmacy Practice, Harrison School of Pharmacy, Auburn University, Auburn, AL 36849-5341, USA.
Department of Pharmacy, Central Alabama Veterans Health Care System, Montgomery, AL 36109, USA.
Pharmacy (Basel). 2020 Jul 24;8(3):129. doi: 10.3390/pharmacy8030129.
Urinary tract infections (UTIs) are a commonly diagnosed problem in long-term care facilities (LTCFs), but antimicrobial treatment is often incorrectly prescribed. Although bacterial resistance to antimicrobials commonly used for UTIs, such as trimethoprim/sulfamethoxazole and fluoroquinolones, has been dramatically increasing, they are still commonly prescribed. The purpose of this project was to determine if implementation of a standard treatment protocol for UTIs, which emphasized correct UTI diagnosis and use of nitrofurantoin and cefpodoxime/ceftriaxone as empiric therapy per the institutional antibiogram, changed clinician prescribing practices. This quasi-experimental model utilized two years of pre-intervention and two years of post-intervention data. Three hundred patient encounters were included. Antibiotics prescribed in the pre-intervention period included: trimethoprim/sulfamethoxazole (32%), ciprofloxacin (14%), amoxicillin (13%), levofloxacin (9%), cefpodoxime (9%), ceftriaxone (8%), amoxicillin/clavulanate (5%), nitrofurantoin (4%), and other (6%). By contrast, antibiotics prescribed in the post-intervention period included: cefpodoxime (46%), nitrofurantoin (30%), ceftriaxone (10%), trimethoprim/sulfamethoxazole (8%), amoxicillin/clavulanate (1%), and other (5%). These differences in prescribed drug between the pre-intervention and post-intervention encounters were statistically significant ( < 0.001). Overall, appropriate empiric treatment was prescribed in only 48/217 encounters (22%) during the pre-intervention period, but this increased to 73/83 encounters (88%) in the post-intervention period ( < 0.001). The results indicate that the treatment protocol was successful in changing prescribing practices and decreasing the use of inappropriate antimicrobials at the LTCF.
尿路感染(UTIs)是长期护理机构(LTCFs)中常见的诊断问题,但抗菌治疗的处方常常有误。尽管用于UTIs的常用抗菌药物(如甲氧苄啶/磺胺甲恶唑和氟喹诺酮类)的细菌耐药性一直在急剧增加,但它们仍被普遍处方。本项目的目的是确定实施UTIs标准治疗方案(该方案强调正确的UTI诊断,并根据机构抗菌谱使用呋喃妥因和头孢泊肟/头孢曲松作为经验性治疗)是否会改变临床医生的处方习惯。这个准实验模型使用了干预前两年和干预后两年的数据。纳入了300例患者就诊情况。干预前期处方的抗生素包括:甲氧苄啶/磺胺甲恶唑(32%)、环丙沙星(14%)、阿莫西林(13%)、左氧氟沙星(9%)、头孢泊肟(9%)、头孢曲松(8%)、阿莫西林/克拉维酸(5%)、呋喃妥因(4%)和其他(6%)。相比之下,干预后期处方的抗生素包括:头孢泊肟(46%)、呋喃妥因(30%)、头孢曲松(10%)、甲氧苄啶/磺胺甲恶唑(8%)、阿莫西林/克拉维酸(1%)和其他(5%)。干预前后就诊处方药物的这些差异具有统计学意义(<0.001)。总体而言,干预前期217例就诊中只有48例(22%)给予了适当的经验性治疗,但在干预后期这一比例增加到了83例中的73例(88%)(<0.001)。结果表明,该治疗方案成功改变了处方习惯,并减少了LTCF中不适当抗菌药物的使用。